COMPARATIVE ANALYSIS OF EPIDURAL ROPIVACAINE 0.75% VERSUS ROPIVACAINE 0.75% WITH CLONIDINE IN LOWER LIMB SURGERIES: EFFICACY, HEMODYNAMICS, AND SAFETY PROFILE

Authors

  • DEVASHISH SINGH SHEKHAWAT Department of Anaesthesia, Jhalawar Medical College, India
  • UPENDRA KUMAR Department of Anaesthesia, Jhalawar Medical College, India
  • YASH VIJAY Department of Anaesthesia, Jhalawar Medical College, India

DOI:

https://doi.org/10.22159/ijcpr.2025v17i1.6027

Keywords:

Epidural anesthesia, Ropivacaine, Clonidine, Lower limb surgery, Postoperative pain, Hemodynamic stability

Abstract

Objective: Epidural ropivacaine is extensively used for lower limb surgeries due to its effective analgesic properties and safety profile. The addition of clonidine as an adjuvant may enhance these effects, but its implications on efficacy, hemodynamics, and safety are not fully established.

Methods: In a double-blind, randomized controlled trial, 80 patients undergoing lower limb surgeries were assigned to receive either ropivacaine 0.75% or ropivacaine 0.75% with clonidine epidurally. Parameters such as onset and duration of sensory and motor blocks, hemodynamic changes, postoperative pain scores, and side effects were meticulously recorded and analyzed.

Results: Clonidine significantly improved the onset and duration of sensory and motor blocks, maintained better hemodynamic stability, and provided superior pain control compared to ropivacaine alone. There were no significant adverse effects requiring intervention beyond standard care.

Conclusion: Clonidine is an effective adjuvant to ropivacaine in epidural anesthesia for lower limb surgeries, enhancing analgesic quality and duration while being hemodynamically stable and safe.

Downloads

Download data is not yet available.

References

Thimmappa T. Efficacy and safety of ropivacaine with clonidine for epidural analgesia in lower limb surgeries. World J Pharm Pharm Sci. 2014;3(4):1223-34.

Shanmugapriya V. Comparative analysis of ropivacaine for epidural use in lower limb surgeries. Int J Med Sci Curr Res. 2023;6(1):742-50.

Karki DB. Comparison of epidural 0.75% ropivacaine and 0.5% levobupivacaine in lower limb surgeries. Int J Sci Study. 2017;4(10):110-2.

Malik AV, Bhan S, Gulati S, Mahajan A. A comparative evaluation of clonidine fentanyl and a combination of both as adjuncts to ropivacaine in epidural block for lower limb surgeries. JK Science. 2020.

Rekha PA. Comparative study of epidural ropivacaine in lower limb surgeries. JMSCR. 2020;8(11):267-72.

Liu S. Efficacy of ropivacaine with dexamethasone in peripheral nerve blocks for lower limb surgeries. Cureus. 2020.

Maca J. Patient-controlled epidural analgesia vs. conventional epidural analgesia in lower limb orthopedic surgeries. Ain Shams J Anesthesiol. 2020.

Pandey SK, Gautam S, Kapoor R, Kumar SV, Agarwal J, Malik A. Comparative study of epidural ropivacaine 0.5% and 0.75% with clonidine for lower limb surgeries. Int J Curr Res. 2024.

Himanshu M, Kumar N, Yadav P, Kaushik S. To evaluate the effects of dexmedetomidine and clonidine as adjuvants to ropivacaine 0.75% for epidural anesthesia in patients undergoing lower limb orthopaedic surgeries. Academic Medicine. 2022.

Chernik DA. Assessment of sedation levels in patients receiving ropivacaine with clonidine for lower limb surgeries. J Clin Anesth. 2021.

Shefali G, Rajni K. Comparative study of epidural ropivacaine alone and with clonidine or dexmedetomidine in lower limb surgeries. Academia. Educ Res. 2022.

Small C, Laycock H. Impact of epidural analgesia on postoperative outcomes in lower limb surgeries. Clin Anesth. 2020.

Renck H, Edstrom H. Benefits of epidural analgesia in orthopedic surgeries. Clin Orthop. 1976.

Rutberg H. A study on the decrease of endocrine response in lower limb surgeries through epidural analgesia. J Pain Manag. 1984.

Published

15-01-2025

How to Cite

SHEKHAWAT, D. S., U. KUMAR, and Y. VIJAY. “COMPARATIVE ANALYSIS OF EPIDURAL ROPIVACAINE 0.75% VERSUS ROPIVACAINE 0.75% WITH CLONIDINE IN LOWER LIMB SURGERIES: EFFICACY, HEMODYNAMICS, AND SAFETY PROFILE”. International Journal of Current Pharmaceutical Research, vol. 17, no. 1, Jan. 2025, pp. 61-64, doi:10.22159/ijcpr.2025v17i1.6027.

Issue

Section

Original Article(s)